Document Classification

Section Type: RESULTS

Text: There were no differences between the vitamin C and placebo groups in percent increases in FBF (% FBF) or platelet cGMP levels (% cGMP) after administration of sublingual nitroglycerin on day O (% FBF : normal volunteers 31 + / -8 vs. 32 + / -10 ; patients with IHD 32 + / -9 vs. 32 + / -8 ; % cGMP : normal volunteers 37 + / -9 vs. 39 + / -10 ; patients with IHD 38 + / -10 vs. 39 + / -10 [vitamin C group vs. placebo group]) or day 3 (% FBF : normal volunteers 32 + / -9 vs. 33 + / -9 ; patients with IHD 31 + / -10 vs. 31 + / -10 ; % cGMP : normal volunteers 36 + / -8 vs. 37 + / -9 ; patients with IHD 39 + / -11 vs. 38 + / -10 [vitamin C group vs. placebo group]).